Início › Câncer Endometrial › Virgínia

Ensaios clínicos de Câncer Endometrial em Virgínia

51 estudos para Câncer Endometrial estão buscando participantes em locais em Virgínia.

Cidades em Virgínia

Texto oficial do estudo (Inglês)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Ballad Health Cancer Care - Bristol, Bristol
University of Virginia Cancer Center, Charlottesville
Inova Schar Cancer Institute, Fairfax
e mais 5

RecrutandoFase 2

Todas as idades · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Virginia Cancer Specialists, Fairfax

RecrutandoFase 1/2

Idades 12 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04585750

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Inova Schar Cancer Institute, Fairfax
NEXT Virginia, Fairfax

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06270706

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

University of Virginia Cancer Center, Charlottesville
VCU Massey Comprehensive Cancer Center, Richmond

RecrutandoFase 3

Idades 18 e acima · Mulheres · Atualizado em 2 de out. de 2026 · NCT07198074

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

University of Virginia, Charlottesville
NEXT Virginia, Fairfax

RecrutandoFase 1

Idades 19 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06586957

A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors

Site 04, Fairfax

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07814248

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

Virginia Commonwealth University/ Massey Cancer Center, Richmond

RecrutandoEstudo observacional

Idades 18 e acima · Mulheres · Atualizado em 29 de set. de 2026 · NCT05051722

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

University of Virginia Cancer Center, Charlottesville

RecrutandoFase 2

Idades 18 e acima · Mulheres · Atualizado em 28 de set. de 2026 · NCT05112601

Study of AVZO-021 in Patients With Advanced Solid Tumors

Avenzo Therapeutics Recruiting Site, Fairfax

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT05867251

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

Virginia Commonwealth University, Richmond

RecrutandoFase 1/2

Idades 18 e acima · Mulheres · Atualizado em 25 de set. de 2026 · NCT03564340

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

University of Virginia Cancer Center, Charlottesville
Virginia Commonwealth University, Richmond

RecrutandoFase 2

Idades 18 e acima · Mulheres · Atualizado em 24 de set. de 2026 · NCT05640999

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

NEXT Oncology Virginia, Fairfax

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06128551

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Virginia Cancer Specialists, Fairfax

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 21 de set. de 2026 · NCT05983432

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

Inova Schar Cancer Institute ( Site 6003), Fairfax
Virginia Cancer Specialists (VCS) ( Site 8008), Fairfax
VCU Health Adult Outpatient Pavillion ( Site 5000), Richmond

RecrutandoFase 3

Idades 18 e acima · Mulheres · Atualizado em 17 de set. de 2026 · NCT06952504

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

NEXT Oncology, Fairfax

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT07109726

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Virginia Cancer Specialists, Fairfax

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 10 de set. de 2026 · NCT06293898

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

University of Virginia, Charlottesville

RecrutandoFase 3

Idades 18 e acima · Mulheres · Atualizado em 9 de set. de 2026 · NCT07166094

Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.

NEXT Oncology, Fairfax

RecrutandoFase 1

Idades 18 e acima · Mulheres · Atualizado em 3 de set. de 2026 · NCT07755436

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Research Site, Charlottesville
Research Site, Fairfax

RecrutandoFase 3

Idades 18 e acima · Mulheres · Atualizado em 3 de set. de 2026 · NCT06989112

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

NEXT Virginia, Fairfax

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 27 de ago. de 2026 · NCT07227168

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

NEXT Virginia, Fairfax

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 26 de ago. de 2026 · NCT07383506

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

University of Virginia, Charlottesville

RecrutandoFase 1

Idades 15 e acima · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT06276491

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

Inova Schar Cancer Institute, Falls Church

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 21 de ago. de 2026 · NCT06774963

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

Research Site, Fairfax

RecrutandoFase 1/2

Idades de 18 a 130 · Todos os sexos · Atualizado em 21 de ago. de 2026 · NCT05797168

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

University of Virginia Health System, Charlottesville

RecrutandoFase 2

Idades 18 e acima · Mulheres · Atualizado em 21 de ago. de 2026 · NCT05548296

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

University of Virginia Health System, Charlottesville

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 19 de ago. de 2026 · NCT04104776

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Normunity Investigational Site, Fairfax

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT07182149

FOG-001 in Locally Advanced or Metastatic Solid Tumors

University of Virginia, Charlottesville

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT05919264

A Study of PHST001 in Advanced Solid Tumors

NEXT Oncology - Virginia, Fairfax

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 12 de ago. de 2026 · NCT06840886

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

NEXT Oncology - Virginia Cancer Specialists, Fairfax

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 5 de ago. de 2026 · NCT07444814

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Virginia Cancer Specialists, Fairfax

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 5 de ago. de 2026 · NCT06330064

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

USOR Virginia Cancer Specialists, Fairfax
USOR Virginia Oncology Associates, Norfolk

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 4 de ago. de 2026 · NCT05579366

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Virginia Cancer Specialists, Fairfax

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 30 de jul. de 2026 · NCT04657068

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Research Site, Fairfax
Research Site, Falls Church
Research Site, Norfolk
e mais 2

RecrutandoFase 3

Idades 18 e acima · Mulheres · Atualizado em 29 de jul. de 2026 · NCT07044336

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

NEXT Virginia, Fairfax

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 22 de jul. de 2026 · NCT05208762

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

NEXT Virginia, Fairfax

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 22 de jul. de 2026 · NCT07524322

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

522, Fairfax
300, Norfolk

RecrutandoFase 2

Idades 18 e acima · Mulheres · Atualizado em 16 de jul. de 2026 · NCT06906341

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

USO-Virginia Cancer Specialists, PC, Fairfax

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 7 de jul. de 2026 · NCT05768139

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

NEXT Virginia, Fairfax

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT07458347

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

NEXT Oncology Virginia, Fairfax

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT05377996

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.